The U.S. Chamber of Commerce’s Global Innovation Policy Center (GIPC) published a blog post Friday urging the U.S. Patent and Trademark Office (USPTO) to resist “misguided ‘coordination’ efforts” such as the Agency’s proposals for increasing collaboration with the Food and Drug Administration (FDA). The USPTO first published a Request for Comments in October 2022 asking the public for input on “proposed initiatives directed at bolstering the robustness and reliability of patents to incentivize and protect new and nonobvious inventions while facilitating the broader dissemination of public knowledge to promote innovation and competition.”

Full Article Available Here